Orion Therapeutics Debuts Antioxidant

TROY -- The biotech firm Orion Therapeutics LLC Monday announced the introduction of Cantavita, a time release antioxidant dietary supplement.

A tablet taken twice daily, Cantavita neutralizes the five major forms of health-damaging free radicals that have been linked to many serious diseases. Many research studies have concluded that elimination of free radicals modulates and maintains healthy cells, tissue and body fluids. Orion Therapeutics believes that Cantavita, a nutraceutical dietary product, will improve general health, wellness and energy levels.

Brunswick Laboratories of Southborough, Mass. and Knight Scientific Ltd. in Plymouth, England have independently verified Cantavita's industry-leading antioxidant test scores. Manufacturing is done in a current Good Manufacturing Procedures compliant facility in Windsor, Ontario, Canada.

"Cantavita is a breakthrough product among dietary supplements," said Frederick A. Valeriote, Ph.D., chief scientific officer of Orion Therapeutics as well as CEO of 21st Century Therapeutics, a biomedical research firm in Ferndale. "Studies show antioxidants are most effective when continuously present in the body. Cantavita's time-release formulation maintains a healthy level of antioxidants, providing users with around-the-clock protection."

Valeriote added: 'At present Cantavita is not targeted to help any particular disease, but we are discussing clinical trials for cancer with medical oncologists in several countries."

Cantavita was developed following a six-year research study and the awarding of a U.S. patent in 2009. It's tablet form and two-per-day regimen makes it convenient, tasteless and low-cost. A single dose costs less than a cup of coffee.

Available from www.cantavita.com, anyone interested can subscribe to Cantavita's email newsletter from the home page.